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Clinical impact of respiratory motion correction in simultaneous PET/MR, using a
joint PET/MR predictive motion model
Abstract
In Positron Emission Tomography (PET) imaging, patient motion due to respiration can lead to artefacts
and blurring, in addition to quantification errors. The integration of PET imaging with Magnetic Resonance
(MR) imaging in PET/MR scanners provides spatially aligned complementary clinical information, and
allows the use of high spatial resolution and high contrast MR images to monitor and correct motioncorrupted PET data. We validate our PET respiratory motion correction methodology based on a joint PETMR motion model, on a patient cohort, showing it can improve lesion detectability and quantitation, and
reduce image artefacts. Methods: We apply our motion correction methodology on 42 clinical PET-MR
patient datasets, using multiple tracers and multiple organ locations, containing 162 PET-avid lesions.
Quantitative changes are calculated using Standardised Uptake Value (SUV) changes in avid lesions.
Lesion detectability changes are explored with a study where two radiologists identify lesions or 'hot
spots', providing confidence levels, in uncorrected and motion-corrected images. Results: Mean increases
of 12.4% for SUV_peak and 17.6% for SUV_max following motion correction were found. In the
detectability study, an increase in confidence scores for detecting avid lesions is shown, with a mean
score of 2.67 rising to 3.01 (out of 4) after motion correction, and a detection rate of 74% rising to 84%. Of
162 confirmed lesions, 49 lesions showed an increase in all three metrics SUV_peak, SUV_max and
combined reader confidence scores, whilst only two lesions showed a decrease. We also present a
number of clinical case studies, demonstrating the effect respiratory motion correction of PET data can
have on patient management, with increased numbers of lesions detected, improved lesion sharpness
and localisation, as well as reduced attenuation-based artefacts. Conclusion: We demonstrate significant
improvements in quantification and detection of PET-avid lesions, with specific case study examples
showing where motion correction has the potential to have an effect on patient diagnosis or care.
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Clinical Impact of Respiratory Motion Correction in
Simultaneous PET/MR, Using a Joint PET/MR Predictive
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Sébastien Ourselin4, Simon Arridge4, and David Atkinson1
1Centre

for Medical Imaging, Division of Medicine, University College London, London, United Kingdom; 2Institute of Nuclear
Medicine, UCL and UCL Hospitals, London, United Kingdom; 3Centre for Medical Radiation Physics, University of Wollongong,
Wollongong, New South Wales, Australia; and 4Centre for Medical Imaging Computing, Faculty of Engineering, University College
London, London, United Kingdom

In PET imaging, patient motion due to respiration can lead to artifacts and blurring, in addition to quantification errors. The integration of PET imaging with MRI in PET/MRI scanners provides spatially
aligned complementary clinical information and allows the use of
high-contrast, high-spatial-resolution MR images to monitor and
correct motion-corrupted PET data. On a patient cohort, we tested
the ability of our joint PET/MRI-based predictive motion model
to correct respiratory motion in PET and show it can improve
lesion detectability and quantitation and reduce image artifacts.
Methods: Using multiple tracers and multiple organ locations, we
applied our motion correction method to 42 clinical PET/MRI patient
datasets containing 162 PET-avid lesions. Quantitative changes
were calculated using SUV changes in avid lesions. Lesion detectability changes were explored with a study in which 2 radiologists
identified lesions in uncorrected and motion-corrected images and
provided confidence scores. Results: Mean increases of 12.4% for
SUVpeak and 17.6% for SUVmax after motion correction were found.
In the detectability study, confidence scores for detecting avid lesions increased, with a rise in mean score from 2.67 to 3.01 (of 4)
after motion correction and a rise in detection rate from 74%
to 84%. Of 162 confirmed lesions, 49 showed an increase in all
3 metrics—SUVpeak, SUVmax, and combined reader confidence
score—whereas only 2 lesions showed a decrease. We also present
clinical case studies demonstrating the effect that respiratory motion correction of PET data can have on patient management, with
increased numbers of detected lesions, improved lesion sharpness
and localization, and reduced attenuation-based artifacts. Conclusion: We demonstrated significant improvements in quantification
and detection of PET-avid lesions, with specific case study examples showing where motion correction has the potential to affect
diagnosis or patient care.
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ecause of the long acquisition duration of PET (typically 3–
15 min per bed position), motion during the acquisition may lead
to blurring in the resulting images and errors in quantification
(1,2). The already limited spatial resolution of PET, around
4.5 mm in full width at half maximum, is effectively reduced
when motion occurs during the acquisition. In oncology, tumors
in the upper abdomen and thorax are particularly adversely affected by respiratory motion because the diaphragm moves by
around 20 mm on average in one breathing cycle (3). Lesions at
anatomic boundaries such as between the liver and lung can also
be mispositioned on PET images when compared with the anatomic reference MR or CT image. Furthermore, quantification is
affected because moving lesions appear smeared, showing an apparent increase in size and decrease in uptake. Motion may also
cause problems with attenuation correction, whereby a static attenuation map does not correlate spatially with the PET emission
data because of moving anatomy (4).
PET respiratory motion can be corrected by gating (splitting
data into respiratory states), reconstructing separate images, and
registering to a common respiratory state (2,5,6). This technique
requires a good signal-to-noise ratio in each gated image for accurate registration. Meeting this requirement becomes difficult
under the pressure to reduce scan times and lower patient doses,
leading to low-count statistics and a lower signal-to-noise ratio in
each gate. The recent advent of PET/MRI scanners allows exploitation of modality simultaneity by using high-contrast, high-spatialresolution tagged MR images to estimate respiratory motion and
correct PET data without additional radiation exposure, with MR
tagging (7,8) or by acquiring quick motion-capturing 2-dimensional
images (9) or low-resolution 3-dimensional images (10).
Although current methods for respiratory motion correction in
PET/MRI show an improvement in PET image quality, all require
a change to the otherwise intended PET/MRI protocol to be able to
collect the respiratory signal or MRI-derived motion model in a
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clinical setting. Many methods use an external monitoring device
to obtain a respiratory signal. However, such devices require time
for set-up and readjustment and can fail because of mispositioning,
patient movement, poor calibration, or signal drift and clipping.
Some methods also require MRI-sequence alteration, which needs to
be set up in advance of the scan, can create artifacts in MR images
near the diaphragm, and may increase scan time.
In recent work, we demonstrated the capability of a joint PET/
MRI-based predictive motion model that was built using data
from a 1-min dynamic MRI sequence with no external hardware
required (11). The method addressed many of the limitations
found for the discrete binning method, which was used in our
previous work (12). In this current work, we performed a pilot
analysis of the method on a larger patient cohort by examining
changes in SUV metrics on attenuation-corrected PET reconstructions and by performing a lesion detectability study. In this study,
2 readers examined each uncorrected and motion-corrected image
and scored their confidence about suspected lesions. We used
these scores to determine the true-positive (TP) and false-positive
(FP) detection rates, as well as changes in confidence between
uncorrected and motion-corrected images. Finally, we present
several examples of how respiratory motion correction may have
the potential to affect clinical patient management in such areas as
staging, diagnosis, and surgical planning.
MATERIALS AND METHODS
Respiratory Motion Correction via Joint PET/MRI-Based
Predictive Motion Model

In our recent work, we described a method of respiratory motion
correction via a joint PET/MRI-based predictive motion model using
1 min of simultaneously acquired PET and MRI data to capture
intercycle and intracycle breathing variations (11). The continuous
nature of the model allows interpolation and extrapolation at any respiratory signal value, meaning 100% of PET data is used in the
reconstruction, and deformation fields are estimated even at extreme
values such as at a deep inhale for the Dixon MRI sequence. All slices
of the free-breathing MRI acquisition are used, with an optimization
scheme to form a model that is robust to registration errors between
single slices. MRI and PET data were also aligned temporally by
including a time shift in the optimization while taking the different
hardware clock-rates into account. The motion model links one or
more surrogate measures of respiratory motion to the tissue deformation. In our previous work, we found the performance to be best when
we used the PET-derived respiratory signal and its gradient in a 2surrogate model. The model used a linear fit to relate the surrogates to
the deformations. This scheme was applied in the current work, on
a larger patient dataset, to estimate deformations throughout the PET
scans.
Study Design

The U.K. Health Research Agency approved this retrospective study,
and the requirement to obtain informed consent was waived. All data
were acquired using an integrated 3-T PET/MRI system (Biograph mMR;
Siemens Healthcare).
Data were retrospectively analyzed from 42 patients who had
undergone PET/MRI between February 2014 and November 2015,
selected on the basis of clinical information suggesting possible avid
regions in the thorax or abdomen. The tracers used were 18F-FDG (24 patients) and 68Ga-DOTATATE (18 patients). The patient cohort consisted
of 18 women and 24 men, with a mean age of 61.9 y (range, 36–85 y).
The PET/MRI protocols included an additional breath-hold DIXON
MRI sequence (for PET attenuation correction) and a 1-min free-
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breathing dynamic MRI sequence (2-dimensional multislice gradientecho sequence, with sagittal slices acquired at 9 locations, covering
the thorax and abdomen, including the lungs, liver, and pancreas). The
dynamic MRI sequence had the following parameters: 10-mm slice
thickness, 25-mm gap between slice centers, 5.1-ms repetition time,
2.5-ms echo time, 10 flip angle, 965-Hz pixel bandwidth, 192 · 144
matrix, 262 · 349 mm field of view, 1.8 · 1.8 mm in-plane resolution,
0.3-s acquisition time per image, and factor 3 integrated parallel acquisition technique (Siemens Healthcare). The data from this 1-min
MRI sequence were used to build the patient-specific motion model.
Four consecutive minutes of PET list-mode data were used for the
PET reconstructions, with a mean interval of 1 h 39 min 6 33 min
from radiotracer injection to PET acquisition. The 4 min of PET data
used here included the 1-min dynamic MRI acquisition and the preceding 3 min.
Data Processing

A motion-compensated reconstruction of 4 min from the PET
acquisition was performed using deformation fields estimated by the
2-surrogate linear model, with PET data gated before reconstruction
using the patient-specific scheme outlined in a previous publication
(11). For motion-corrected reconstructions, the attenuation m-map was
warped to each gate with deformation fields estimated by the motion model, using the values of the surrogate signal during the Dixon
MRI acquisition. For uncorrected reconstructions, the acquired static
m-map was used. An ordered-subset expectation maximization reconstruction algorithm was applied, with 21 subsets, 3 iterations, 4-mm
gaussian postfiltering, and correction of random events and scatter
events.
PET data processing (e.g., unlisting and reconstruction) was performed
with STIR (Software for Tomographic Image Reconstruction) (13). All
other analyses were performed with Matlab (MathWorks, Inc.), and MIRT
(Medical Image Registration Toolbox) (14) was used in Matlab for
registration.
Analysis

Lesion Detectability Study. The effect of motion correction on
lesion detectability and localization was assessed. Two accredited
radiologists viewed the uncorrected and motion-corrected PET images
for each patient dataset without seeing the structural MR images. The
viewing was done individually by each reader, and blinded to whether
each image was uncorrected or corrected. The images were read in 2
sets, with the uncorrected and motion-corrected images for each
patient split between the 2 sets randomly, and with at least a 2-wk
interval between readings of each set to minimize recall bias. Each
reader was free to scroll through the slices and adjust the color scales.
The readers were asked to mark foci of uptake that might represent a
pathologic change and influence clinical decisions. We use the term
lesion to describe any marked area. The readers gave each mark a
score, x, on a 4-point scale to indicate their confidence that a lesion
was present at that location (x 5 1, questionable [ , 50% likely]; x 5
2, possible [50%–75% likely]; x 5 3, probable [75%–95% likely];
x 5 4 [definite; . 95% likely]). The scores provided by readers 1 and
2 are referred to as x1 and x2, respectively. The perceived anatomic
location of each lesion on the uncorrected and motion-corrected PET
images was also documented by the readers.
For the purpose of this study, the reference standard used to define
the presence and locations of lesions was a consensus reading by the
radiologists using a combination of all imaging studies, including the
original uncorrected PET study, the MRI component of the hybrid
PET/MRI study, contemporaneous clinical MRI and CT studies, and
all available follow-up imaging (CT, MRI, PET). Lesions marked by
the readers on the uncorrected and motion-corrected images were
visually checked against the reference reading. Any marked lesion
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TABLE 1
Lesions in Patient Cohort

Of the 162 reference lesions, 72 were also confirmed to be
present on MRI, 7 on CT, and 62 on both MRI and CT. Twentyone lesions were confirmed either from PET follow-up or from the
original uncorrected PET study along with patient history and
clinical information. The quantitative analysis results are provided
in Table 2.

n

Lesion
Liver

71

Pancreas

22

Lung

27

Abdominal node

Lesion Detectability

6

Thoracic node

29

Other*

7

Total

162

*Kidney, bowel, rib, or shoulder.

that matched a reference lesion was defined as a TP, any reference
lesion that was not marked was defined as a false-negative and given a
score of 0, and any marked lesion that did not match a reference lesion
was defined as an FP.
A change in the x score, Dx, for any lesion in the TP or FP set
was defined as the x score for the motion-corrected image minus
the x score for the uncorrected image. For readers 1 and 2, these
are referred to as Dx1 and Dx2, respectively. An increase in these
scores after motion correction represents an increase in detection
confidence, and a decrease represents a decrease in detection
confidence.
SUV Analysis. Changes in 2 SUV metrics for lesions were assessed:
DSUVpeak, defined as the maximum average activity concentration
within a 12-mm-diameter sphere inside a manually defined region
of interest (15), and DSUVmax, defined as the maximum voxel SUV
inside the region of interest.
Statistical Analysis. The significance of differences in x scores between uncorrected and motion-corrected images was determined with
the Wilcoxon signed rank test. For the SUV metrics of lesions, a
paired-sample t test was used.
RESULTS

The reference reading identified 162 PET-positive lesions (74
for 68Ga-DOTATATE and 88 for 18F-FDG) in 32 patients. These
were in the form of liver, pancreas, kidney, bowel, rib, and shoulder lesions, as well as an assortment of nodes and areas of benign
uptake. These are summarized in Table 1. Ten patients had no
identifiable lesions.

The TP rate, or sensitivity, for uncorrected and motioncorrected images was 85% and 95%, respectively, for reader 1
and 62% and 73%, respectively, for reader 2. The 2 readers’
average TP rate for the 162 lesions was 74% (68Ga-DOTATATE,
79%; 18F-FDG, 69%) in the uncorrected images, rising to 84%
(68Ga-DOTATATE, 89%; 18F-FDG, 80%) in the motion-corrected images.
Figure 1 shows the Dx scores for TP results, with a positive
change indicating an increase in lesion detectability. Figure 1A
shows the Dx distribution for all 162 lesions for each reader separately. Considering the average of Dx1 and Dx2 over all 162
lesions, 8% (13 lesions) showed a decrease in x score, 69%
(112 lesions) showed no change, and 23% (37 lesions) showed
an increase. Between the 2 readers, there was a significant increase
in the mean x score for TP results, from 2.67 (68Ga-DOTATATE,
2.92; 18F-FDG, 2.46) in the uncorrected images to 3.01 (68GaDOTATATE, 3.21; 18F-FDG, 2.85) in the motion-corrected images
(P , 0.0001).
Figure 1B shows the summed x scores, Dx112, for each lesion.
Overall, 11% (18 lesions) showed a decrease (range, 24 to 21),
53% (86 lesions) showed no change, and 36% (58 lesions) showed
an increase (range, 11 to 18).
There was a significant increase in Dx112 from the uncorrected
images to the motion-corrected images, for all TP lesions (P ,
0.0001).
We aimed to reduce the intrinsic intra- and interobserver
variability of the scoring test by examining cases in which the Dx1
and Dx2 of a lesion were either both positive or both negative and
in which the readers agreed on whether detectability had increased
or decreased. This was the case for 14 lesions, with 1 lesion
showing a negative change for both readers (range, 21 to 22)
and 13 lesions showing a positive change for both readers (range,
11 to 14). For 4 of these lesions, the x score changed from 0 in
the uncorrected images (i.e., the lesions were invisible to both
readers) to some degree of detectability in the motion-corrected
images.

TABLE 2
Quantitative Analysis Results for All 162 Lesions
Metric

Uncorrected

Motion-corrected

Paired significance

SUVpeak

17.6 ± 18.0

19.5 ± 20.1

P , 0.0001 (t test)

SUVmax

22.7 ± 22.6

26.6 ± 29.9

P , 0.002 (t test)

χ score

2.67 ± 1.50

3.01 ± 1.29

P , 0.0001 (Wilcoxon)

TP rate (%)

74

84

NA

FP lesions (n)

30

21

NA

NA 5 not applicable.
SUV metrics are means across all reference lesions. Detection score χ and TP rate are means across both readers. FP number is from
84 datasets (42 patients · 2 readers). Statistical significance is based on paired scores from uncorrected and motion-corrected datasets.
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Cross-Study Correlation

Overall, considering the 3 metrics
DSUVpeak, DSUVmax, and Dx112 for the
162 reference lesions, 2 lesions showed a
decrease in all metrics and 49 showed an
increase in all metrics. The lesions that
showed a negative change were a mediastinal lymph node lesion and a bowel lesion.
Clinical Case Studies

We present several case studies to show
the effects of motion correction on PET
images, considering potential to affect clinical management. The clinical MR images
FIGURE 1. Change in detection score χ for TP lesions between uncorrected and motion-coreither were acquired at exhale breath-hold or
rected images for readers 1 and 2 separately (A) and together (B). White bars represent number of
were triggered, with data collected only at
lesions with specific score changes. Hatched bars are total number of lesions with negative or
the exhale position. Uncorrected and mopositive changes in score, where a positive change is “good” (i.e., TP lesions are more detectable
after motion correction).
tion-corrected images are displayed with
the same color scale for each case study.
Case Study 1: New Lesions Detected, with MRI Confirmation.
The total number of FP results, combining both readers, was
30 (68Ga-DOTATATE, 7; 18F-FDG, 23) in uncorrected images Case study 1 is a 68Ga-DOTATATE PET scan of a patient (falling
and 21 (68Ga-DOTATATE, 8; 18F-FDG, 13) in motion-corrected within the age range of 70–80 y) who had recurrent neuroendoimages. Overall, 27 lesions showed a decrease in x score, 3 crine liver metastases after partial hepatectomy. A contemporanelesions showed no change, and 16 lesions showed an increase, ous MRI study showed at least 2 suspected lesions in the remnant
for marked areas assumed not to be true lesions based on the liver and several smaller deposits that were of concern.
In total, the Dx112 scores for 3 very small lesions was
reference reading.
[11,11,11], with 6 of the total readings (3 lesions · 2 readers)
SUV Analysis
showing that the 3 lesions were newly detected in the motion-corOver all 162 reference lesions, motion correction resulted in a rected images. All 3 were found to be present in the MR images in
significant increase in both SUVpeak (P , 0.0001) and SUVmax the reference reading. Figure 3A shows one of the newly detected
(P , 0.002), with a mean increase in SUVpeak of 12.4% (68Ga- lesions in uncorrected and motion-corrected images, with the conDOTATATE, 12.6%; 18F-FDG, 12.2%) and a mean increase in trast of the lesion being much higher in the motion-corrected
SUVmax of 17.6% (68Ga-DOTATATE, 17.2%; 18F-FDG, 17.9%).
image. The SUV results were confirmatory, with increases in
Figure 2 shows DSUVpeak and DSUVmax for all lesions. Of all the SUV metrics for the 3 lesions (Fig. 3B).
lesions, 14% (22 lesions) showed a decrease in SUVpeak and 86%
At least 3 lesions showed DOTATATE avidity, suggesting
(140 lesions) showed an increase, whereas 17% (27 lesions) metastatic neuroendocrine lesions. This information would influence
showed a decrease in SUVmax and 83% (135 lesions) showed an decisions on the choice of treatment, which may be drug treatment
increase.
(e.g., octreotide analog), percutaneous ablation, or resection.
Defining a ‘‘considerable’’ change as a change greater than 5%
Case Study 2: New Lesions Detected, with PET Follow-up
for both DSUVpeak and DSUVmax, 3% (5 lesions) showed a con- Confirmation. Case study 2 is a 68Ga-DOTATATE PET scan of a
siderable decrease, 43% (69 lesions) showed an inconsiderable patient (falling within the age range of 40–50 y) known to have
change, and 54% (88 lesions) showed a considerable increase. multiple endocrine neoplasia syndrome type 1 and pancreatic leThe 5 lesions that showed a considerable decrease were 1 lung sions. A PET/MRI scan was requested to assess lesion uptake and
node lesion, 1 lung lesion, 1 rib lesion, and 2 bowel lesions.
determine the possible surgical approaches.

FIGURE 2. Histogram of all 162 reference lesions for the metrics
DSUVpeak (A) and DSUVmax (B).
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FIGURE 3. Case 1. Axial uncorrected (U) and motion-corrected (MC)
PET images of lesion 1, along with T1-weighted Dixon volumetric interpolated breath-hold examination PET/MR image and MR image
alone.
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FIGURE 4. Case 2. Axial uncorrected (U) and motion-corrected (MC)
PET maximum-intensity projection (MIP) images showing 3 pancreas
lesions (arrows) at baseline and follow-up, along with T1-weighted Dixon
volumetric interpolated breath-hold examination PET/MR images.

Although the lesions were not verified in the MR images
available, 6 lesions were confirmed as present in the reference
reading because of visibility in a follow-up scan performed 1 y
later (Fig. 4).
The increased number of detected lesions in the baseline scan is
crucial. Accurate mapping of the number and location of tumors in
the pancreas is critical for evaluating the risk versus the benefit of
surgical intervention and for planning the surgery if pursued. The
larger the extent of the pancreatectomy, the more complex the
surgery would be and the greater would be the risk of subsequent
diabetes as a complication.
Case Study 3: Change in Lesion Location. Case study 3 is an
18F-FDG PET scan of a patient (falling within the age range of

40–50 y) with known liver metastases found in a previously acquired CT scan.
For one reader, the location of the lesion changed from lung to
liver after motion correction. The reference reading for this patient
showed 8 lesions, all of which were confirmed to be in the liver on
the MR images. In PET maximum-intensity projections (Fig. 5A),
the location of 2 lesions at the lung–liver interface was unclear in
both the non–attenuation-corrected and the attenuation-corrected
images, but the motion-corrected image clearly showed that the
lesions were in the liver. The spatial alignment of the fused PET
and MR images was better when motion was corrected than when
it was not (Fig. 5B).
This large change in location was due to inadvertent acquisition of
the Dixon MR image at a deep exhale. Motion correction of the
resulting misalignment meant a large DSUVpeak (1142% and
1366%) for the lesions that appeared to move from the lung in the
uncorrected image to the liver in the motion-corrected image.
Motion correction of lesion localization is important for staging
and treatment planning. Involvement of more organs by metastases could potentially change disease stage, influence treatment
decisions, and imply a different prognosis.
Case Study 4: Change in Intralesional Activity Distribution.
Case study 4 is a 68Ga-DOTATATE PET scan of a patient (falling
within the age range of 60–70 y) in whom the x scores showed either
no change or a slight increase in the 11 lesions identified in the reference reading. The shape of the activity distribution in 3 of these lesions
was changed by motion correction (Fig. 6). These were necrotic lesions
showing uptake only at the outer edge.
Although lesion detection and localization did not significantly
change, the distribution of intralesional uptake may be of clinical
importance. For example, a change in distribution may influence
the perceived optimal site for PET-directed biopsy in some patients
or for PET-guided intensity-modulated radiation therapy in others.
Case Study 5: Artifact Reduction. Case study 5 is a 68GaDOTATATE PET scan of a patient (falling within the age range
of 50–60 y) whose uncorrected image showed a banana artifact at the
top of the liver due to a misaligned attenuation map (Fig. 7). Removal
of the artifact was clearly seen in the motion-corrected image, as well
as restoration of the shape of the high stomach uptake to the shape
seen in the MR image. The motion-corrected PET image spatially
aligned better with the MR image.

DISCUSSION

FIGURE 5. Case 3. (A) Maximum-intensity projection (MIP) non–attenuation-corrected, non–
motion-corrected (NAC U); attenuation-corrected, non–motion-corrected (U); and attenuationcorrected, motion-corrected (MC) PET images. (B) Axial PET slice with 3 lesions (arrows) that
wrongly appear in lung in uncorrected image (U) and correctly appear in liver in motion-corrected
image (MC), along with T2-weighted half-Fourier–acquired single-shot turbo spin-echo PET/MR
images and MR image alone.
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This work constitutes a pilot clinical
validation of our joint PET/MRI-based predictive motion model. The PET respiratory
motion correction method produced significant increases in all tested metrics in reference lesions, with mean increases of 12.4%
and 17.6% in SUVpeak and SUVmax, respectively, in 162 PET-avid lesions. We also
showed an increase in the x scores of readers
in detecting avid lesions, with a mean score of
2.67 rising to 3.01 through motion correction, and a TP rate of 74% rising to 84%.
Only 2 lesions showed a decrease in all
3 metrics (SUVpeak, SUVmax and Dx112),
whereas 49 lesions showed an increase in
all metrics.
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FIGURE 6. Case 4. Coronal and axial uncorrected (U) and motioncorrected (MC) PET images, along with T1-weighted volumetric interpolated breath-hold examination spectral attenuated inversion recovery
PET/MR images showing change in shape of uptake in necrotic lesion,
and MR image alone. Arrows show the area where there was artifacts,
which are no longer present in MC image.

Several clinical examples were presented to demonstrate the
range of positive effects of respiratory motion correction with our
method, including newly detected lesions, increased lesion sharpness, reduced artifacts, improved lesion localization, and improved visualization of intralesional activity distribution.
In the SUV analysis (Fig. 2), the apparent outliers arose from
good results, with the large increases in lesion SUVpeak and SUVmax
being due to correction of attenuation map misalignment. In the
only 5 lesions that showed a considerable (more than 5%) decrease in SUV, the decrease could have been due to their location.
Two of these lesions (including that with the largest decrease,
25%) were in the bowel, an area in which the model cannot predict motion because bowel motion is sporadic and unrelated to
respiration. Another lesion was on a rib, a location in which the
deformation estimation might be poor because the registration
scheme lacks a sliding motion. The remaining 2 lesions were in
the lung of a patient with a large lung mass, potentially causing
unpredictable breathing patterns.
When the combined x scores from both readers were considered,
11% of lesions showed a decrease in detectability and 36% showed
an increase, with the range of x scores being much smaller in the
decreased-detectability set (24 to 21, vs. 11 to 18).
One limitation of the detectability study was intra- and interobserver variability in interpretation. The interobserver variability
was higher than might be expected for a PET study focusing on a
specific clinical context. However, the study used multiple cohorts
of patients and diseases. In addition, the detectability assessment
was initially done in isolation, without clinical patient information

or structural information from MRI or CT. We attempted to
overcome this limitation by analyzing the results from both
readers together. For example, when we looked at only the results
for which Dx was either positive or negative for both readers in all
reference lesions, we found that 13 lesions showed an increase in
detectability and only 1 showed a decrease. However, this single
lesion had a higher SUVpeak and SUVmax in the motion-corrected
image than in the uncorrected image, suggesting that the negative
Dx was also due to human error.
A recommended approach for testing lesion detectability is
free-response receiver-operating-characteristic analysis (16). We
did not perform such an analysis because our study lacked a
consistent reference standard and had no definite method to identify FPs. In the literature, PET-based detection studies revolving
around testing of different reconstruction methods (17), different
acquisition times (18), different methods of motion correction (19),
or time-of-flight impact (20) use phantom or simulated PET data for
which ground truth is known. The information that PET provides is
unique in that it portrays tracer uptake, which is unique to the
modality. For example, a lesion may appear avid in a PET image
but may not necessarily be visible in an MR or CT image.
The lack of a definite way to define FPs (a PET-avid lesion that
is not apparent on MRI or CT) applies to our result for the FP rate
(30 lesions detected in the uncorrected images and 21 in the
motion-corrected images, from 84 datasets [42 patients · 2 readers]). These lesions were marked as FPs because evidence of a true
lesion was lacking in the patient information or in the results of
other imaging modalities, but in reality, some of these FPs may
have been real lesions.
We consider this study a pilot analysis of our method. With a
streamlined pipeline and enhanced data-processing efficiency, the
method can be adopted into routine practice, which in turn would
provide the substrate needed for wider clinical validation.
CONCLUSION

We have demonstrated significant improvements in quantification and detection of PET-avid lesions using multiple tracers and
in multiple organ locations, with specific case examples showing
where motion correction has the potential to affect diagnosis or
patient care.
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‘‘Michael Winterdahl.’’ The authors regret the error.
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